Clinical Trial Update: An Exploratory Trial of AZD3480 (TC-1734) for the Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 2 exploratory trial of AZD3480 (TC-1734) for adult attention-deficit/hyperactivity disorder. It is a completed Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• AZD3480 (TC-1734) (AZD3480)

Snippet

Sponsor: AstraZeneca | Conditions: ADHD | Phase 2 | Status: COMPLETED